Prior authorization for pregabalin in commercial insurance plans accomplished the objective of lower pregabalin utilization; however, there was no significant decrease in disease-related healthcare costs.
Robert J. Sanchez, MS
Advertisement
Articles by Robert J. Sanchez, MS
Advertisement
Latest Updated Articles
- Healthcare Utilization and Cost Effects of Prior Authorization for Pregabalin in Commercial Health Plans
Published: June 10th 2010 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Imlunestrant for ER+ and HER2-Negative Breast Cancer
2
In Primary Care–Oncology Collaboration, the Baton Goes Both Ways
3
Marathon Health, Medbridge Partner to Launch Integrated Virtual MSK Care Program
4
Myasthenia Gravis–Induced Fears of Diagnosed Patients During the Pandemic
5
